Diabetes and Cardiovascular Disease When it comes to lipids, statins are all you need

被引：6
|
作者：
Bitzur, Rafael [1 ]
机构：
[1] Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, Ramat Gan, Israel
来源：
DIABETES CARE | 2011年 / 34卷
关键词：
CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN; RISK-FACTORS; FOLLOW-UP; MORTALITY; MELLITUS; THERAPY; INDIVIDUALS; CHOLESTEROL; PEOPLE;
D O I：
10.2337/dc11-s256
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S380 / S382
页数：3
相关论文
共 50 条
  • [31] Do all patients with coronary heart disease or diabetes need statin?
    Poess, Janine
    Boehm, Michael
    Laufs, Ulrich
    MEDIZINISCHE KLINIK, 2009, 104 (01) : 74 - 78
  • [32] Diabetes mellitus, subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality
    Kuller, LH
    Velentgas, P
    Barzilay, J
    Beauchamp, NJ
    O'Leary, DH
    Savage, PJ
    CIRCULATION, 1999, 99 (08) : 1114 - 1114
  • [33] Hypoglycaemia, Abnormal Lipids, and Cardiovascular Disease among Chinese with Type 2 Diabetes
    Li, Yijun
    Mu, Yiming
    Ji, Qiuhe
    Huang, Qin
    Kuang, Hongyu
    Ji, Linong
    Yang, Xilin
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [34] Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus
    van Dieren, S.
    Noethlings, U.
    van der Schouw, Y. T.
    Spijkerman, A. M. W.
    Rutten, G. E. H. M.
    van der A, D. L.
    Sluik, D.
    Weikert, C.
    Joost, H. G.
    Boeing, H.
    Beulens, J. W. J.
    DIABETOLOGIA, 2011, 54 (01) : 73 - 77
  • [35] Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus
    S. van Dieren
    U. Nöthlings
    Y. T. van der Schouw
    A. M. W. Spijkerman
    G. E. H. M. Rutten
    D. L. van der A
    D. Sluik
    C. Weikert
    H. G. Joost
    H. Boeing
    J. W. J. Beulens
    Diabetologia, 2011, 54 : 73 - 77
  • [36] PCI or ITA for Proximal LAD Disease: Where Is the Heart Team When You Need It?
    Hicks, George L.
    ANNALS OF THORACIC SURGERY, 2021, 112 (02): : 562 - 563
  • [37] Statins and New-Onset Diabetes in Cardiovascular and Kidney Disease Cohorts: A Meta-Analysis
    Kamran, Haroon
    Kupferstein, Eric
    Sharma, Navneet
    Karam, Jocelyne G.
    Myers, Alyson K.
    Youssef, Irini
    Sowers, James R.
    Gustafson, Deborah R.
    Salifu, Moro O.
    McFarlane, Samy I.
    CARDIORENAL MEDICINE, 2018, 8 (02) : 105 - 112
  • [38] Predicting pediatric kidney disease progression-are 3 variables all you need?
    Crane, Clarkson R.
    Garimella, Pranav S.
    Heinze, Georg
    KIDNEY INTERNATIONAL, 2023, 104 (05)
  • [39] Cardiovascular disease with diabetes or the metabolic syndrome: should statins or fibrates be first line lipid therapy?
    Robins, SJ
    CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (06) : 575 - 583
  • [40] Meta-Analysis of Effect and Efficacy of Statins in Type 2 Diabetes Mellitus with Cardiovascular Disease
    Li, Xiyu
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 86 : 174 - 182
12345